105 related articles for article (PubMed ID: 23792609)
1. Preference-based utility scores for adverse events associated with the treatment of gynecologic cancers.
Jewell EL; Smrtka M; Broadwater G; Valea F; Davis DM; Nolte KC; Valea R; Myers ER; Havrilesky LJ
Int J Gynecol Cancer; 2013 Jul; 23(6):1158-66. PubMed ID: 23792609
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Health State Utility Measures in Patients With Head and Neck Cancer.
Noel CW; Lee DJ; Kong Q; Xu W; Simpson C; Brown D; Gilbert RW; Gullane PJ; Irish JC; Huang SH; O'Sullivan B; Goldstein DP; de Almeida JR
JAMA Otolaryngol Head Neck Surg; 2015 Aug; 141(8):696-703. PubMed ID: 26204439
[TBL] [Abstract][Full Text] [Related]
3. Determination of quality of life-related utilities for health states relevant to ovarian cancer diagnosis and treatment.
Havrilesky LJ; Broadwater G; Davis DM; Nolte KC; Barnett JC; Myers ER; Kulasingam S
Gynecol Oncol; 2009 May; 113(2):216-20. PubMed ID: 19217148
[TBL] [Abstract][Full Text] [Related]
4. Health State Utilities for Patient's Current Health from Bipolar Type I Disorder.
Banihashemian M; Rashidian A; Gholamian F; Parsaeian M; Moradi N; Amini H
J Ment Health Policy Econ; 2018 Mar; 21(1):3-10. PubMed ID: 29643263
[TBL] [Abstract][Full Text] [Related]
5. Social preferences for health states associated with acute myeloid leukemia for patients undergoing treatment in the United Kingdom.
Castejón N; Cappelleri JC; Cuervo J; Lang K; Mehta P; Mokgokong R; Mamolo C
Health Qual Life Outcomes; 2018 Apr; 16(1):66. PubMed ID: 29669568
[TBL] [Abstract][Full Text] [Related]
6. Utility assessment in patients with mental disorders: validity and discriminative ability of the time trade-off method.
König HH; Günther OH; Angermeyer MC; Roick C
Pharmacoeconomics; 2009; 27(5):405-19. PubMed ID: 19586078
[TBL] [Abstract][Full Text] [Related]
7. The utility score of epilepsy with partial seizure measured by TTO, VAS, and EQ-5D in the general Korean population.
Kang HJ; Kang E; Jo MW; Park EJ; Yoon S; Lee EK
Epilepsy Res; 2014 Jul; 108(5):963-71. PubMed ID: 24679945
[TBL] [Abstract][Full Text] [Related]
8. Comparison of different valuation methods for population health status measured by the EQ-5D in three European countries.
Bernert S; Fernández A; Haro JM; König HH; Alonso J; Vilagut G; Sevilla-Dedieu C; de Graaf R; Matschinger H; Heider D; Angermeyer MC;
Value Health; 2009; 12(5):750-8. PubMed ID: 19490564
[TBL] [Abstract][Full Text] [Related]
9. Health state utilities for metastatic breast cancer in Taiwan.
Chou TC; Chiang SC; Ko Y
Breast; 2020 Jun; 51():57-64. PubMed ID: 32213442
[TBL] [Abstract][Full Text] [Related]
10. Quality of life after treatment for gynecologic malignancies: a pilot study in an outpatient clinic.
Miller BE; Pittman B; Case D; McQuellon RP
Gynecol Oncol; 2002 Nov; 87(2):178-84. PubMed ID: 12477448
[TBL] [Abstract][Full Text] [Related]
11. Valuation of pemphigus vulgaris and pemphigus foliaceus health states: a convenience sample experiment.
Rencz F; Brodszky V; Stalmeier PF; Tamási B; Kárpáti S; Péntek M; Baji P; Mitev AZ; Gulácsi L
Br J Dermatol; 2016 Sep; 175(3):593-9. PubMed ID: 27062497
[TBL] [Abstract][Full Text] [Related]
12. Patient reported late effects of gynecological cancer treatment.
Grover S; Hill-Kayser CE; Vachani C; Hampshire MK; DiLullo GA; Metz JM
Gynecol Oncol; 2012 Mar; 124(3):399-403. PubMed ID: 22119992
[TBL] [Abstract][Full Text] [Related]
13. Assessing utility values in rheumatoid arthritis: a comparison between time trade-off and the EuroQol.
Ariza-Ariza R; Hernández-Cruz B; Carmona L; Dolores Ruiz-Montesinos M; Ballina J; Navarro-Sarabia F;
Arthritis Rheum; 2006 Oct; 55(5):751-6. PubMed ID: 17013822
[TBL] [Abstract][Full Text] [Related]
14. Health-state valuations for pertussis: methods for valuing short-term health states.
Lee GM; Salomon JA; LeBaron CW; Lieu TA
Health Qual Life Outcomes; 2005 Mar; 3():17. PubMed ID: 15780145
[TBL] [Abstract][Full Text] [Related]
15. Logical Inconsistencies in 3 Preference Elicitation Methods for EQ-5D Health States: A Study in the Brazilian Population.
Andrade MV; Noronha K; Kind P; Reis Cde B; de Carvalho LR
Med Decis Making; 2016 Feb; 36(2):242-52. PubMed ID: 26289747
[TBL] [Abstract][Full Text] [Related]
16. Sagittal craniosynostosis: a utility outcomes study.
Kuta V; McNeely PD; Walling S; Bezuhly M
J Neurosurg Pediatr; 2017 Aug; 20(2):113-118. PubMed ID: 28524791
[TBL] [Abstract][Full Text] [Related]
17. Quality-of-life valuations of advanced breast cancer by New Zealand women.
Milne RJ; Heaton-Brown KH; Hansen P; Thomas D; Harvey V; Cubitt A
Pharmacoeconomics; 2006; 24(3):281-92. PubMed ID: 16519549
[TBL] [Abstract][Full Text] [Related]
18. Valuing Treatments for Parkinson Disease Incorporating Process Utility: Performance of Best-Worst Scaling, Time Trade-Off, and Visual Analogue Scales.
Weernink MG; Groothuis-Oudshoorn CG; IJzerman MJ; van Til JA
Value Health; 2016; 19(2):226-32. PubMed ID: 27021757
[TBL] [Abstract][Full Text] [Related]
19. Does cancer risk affect health-related quality of life in patients with Barrett's esophagus?
Gerson LB; Ullah N; Hastie T; Goldstein MK
Gastrointest Endosc; 2007 Jan; 65(1):16-25. PubMed ID: 17185075
[TBL] [Abstract][Full Text] [Related]
20. Utility elicitation study in the UK general public for late-stage chronic lymphocytic leukaemia.
Tolley K; Goad C; Yi Y; Maroudas P; Haiderali A; Thompson G
Eur J Health Econ; 2013 Oct; 14(5):749-59. PubMed ID: 22941034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
